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Abstract
The objectives of this study were to evaluate and compare the use of linear and nonlinear methods for analysis of heart rate 
variability (HRV) in healthy subjects and in patients after acute myocardial infarction (AMI). Heart rate (HR) was recorded for 
15 min in the supine position in 10 patients with AMI taking β-blockers (aged 57 ± 9 years) and in 11 healthy subjects (aged 53 
± 4 years). HRV was analyzed in the time domain (RMSSD and RMSM), the frequency domain using low- and high-frequency 
bands in normalized units (nu; LFnu and HFnu) and the LF/HF ratio and approximate entropy (ApEn) were determined. There 
was a correlation (P < 0.05) of RMSSD, RMSM, LFnu, HFnu, and the LF/HF ratio index with the ApEn of the AMI group on the 
2nd (r = 0.87, 0.65, 0.72, 0.72, and 0.64) and 7th day (r = 0.88, 0.70, 0.69, 0.69, and 0.87) and of the healthy group (r = 0.63, 
0.71, 0.63, 0.63, and 0.74), respectively. The median HRV indexes of the AMI group on the 2nd and 7th day differed from the 
healthy group (P < 0.05): RMSSD = 10.37, 19.95, 24.81; RMSM = 23.47, 31.96, 43.79; LFnu = 0.79, 0.79, 0.62; HFnu = 0.20, 
0.20, 0.37; LF/HF ratio = 3.87, 3.94, 1.65; ApEn = 1.01, 1.24, 1.31, respectively. There was agreement between the methods, 
suggesting that these have the same power to evaluate autonomic modulation of HR in both AMI patients and healthy subjects. 
AMI contributed to a reduction in cardiac signal irregularity, higher sympathetic modulation and lower vagal modulation.
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The integrity of autonomic modulation of heart rate (HR) 
is evaluated by analyzing heart rate variability (HRV), which 
refers to oscillations in the intervals between consecutive 
heartbeats, or R-R intervals (RRi) (1). This method for evalu-
ation is employed in a variety of clinical applications, being 
extensively used in cardiology due to its noninvasiveness, 
ease of application and high reproducibility (1,2).
It has been well established that autonomic HR regula-
tion is associated with the integrity of complex interactions 
between electrophysiological, humoral and hemodynamic 
variables (2,3). However, HR is considered to present nonlin-
ear behavior due to the complex interaction between several 
systems (central nervous system, reflex mechanisms and 
neurohumoral factors) (3-7).
The literature indicates that linear methods have been 
widely explored and are considered to be appropriate for 
the study of HRV (8-12). Nevertheless, interest in nonlinear 
methods has increased in recent years (4-7,13-15) due to 
observations that HR fluctuation is subordinate to autonomic 
nervous system control of cardiac activity and vascular 
dynamics (14), which suggests that the mechanisms in-
volved in cardiovascular regulation interact with and have 
repercussions on other organs. 
Among nonlinear methods, approximate entropy (ApEn) 
allows the evaluation of regular time series and is used to 
analyze physiological and clinical data (13,14). Thus ApEn 
provides quantitative information about the complexity of 
or reduction in the chaotic behavior of the signal of both 
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short-term and long-term data recordings (2-4,13-15). 
The application of ApEn to cardiac signal analysis pro-
vides information about the autonomic modulation of HR, 
considering that increased signal regularity is related to 
pathological situations such as acute myocardial infarction 
(AMI). A study that evaluated HRV for an average period 
of 30 days post-AMI without the use of β-blockers found 
no correlation between the indexes of linear and nonlinear 
methods. Moreover, in this same study greater irregular-
ity in HR dynamics was observed in AMI patients than in 
healthy subjects (2).
Santos-Hiss et al. (10), using linear models to evaluate 
the short-term evolution of the autonomic modulation of HR 
in patients taking β-blockers and receiving routine clinical 
intervention, observed no modification of HRV indexes 
between the 1st and 6th day after AMI.
Thus, the hypothesis of the present study was that both 
the application of a nonlinear method like ApEn and linear 
methods in the time and frequency domains could be used 
to identify and evaluate the HR dynamics of both post-AMI 
patients who take β-blockers and healthy individuals. Ad-
ditionally, post-AMI patients presented alterations in the 
dynamics of autonomic modulation of HR compared to 
healthy subjects.
The objectives of the present study were: 1) to evalu-
ate the relationship between HRV analysis in the time and 
frequency domains with ApEn in both post-AMI patients tak-
ing β-blockers and healthy individuals; 2) to compare HRV 
indexes on the 2nd and 7th day after AMI; 3) to compare 
the HRV indexes between AMI and healthy groups.
Material and Methods
Design and subjects 
Sixty-four men (36 with AMI and 28 healthy subjects) 
ranging in age from 50 and 65 years volunteered for the 
study through personal invitation or advertising. In this 
group, 10 men with AMI (57 ± 9 years old) and 11 healthy 
men (54 ± 3 years old) were enrolled and completed the 
study. Figure 1 is a flow diagram presenting the sample 
loss in detail. 
The AMI group was selected from two hospitals in the 
State of São Paulo, Brazil: the coronary units of Hospital 
dos Fornecedores de Cana in the city of Piracicaba and 
the Santa Casa de Misericórdia in the city of Limeira. Of 
the 36 volunteers who had been admitted to the coronary 
unit and diagnosed with AMI, 10 were included in the study. 
They had all been submitted to Doppler echocardiography 
and cardiac catheterization with chemical or mechanical 
reperfusion in the first hours after the diagnosis of AMI, 
had been using β-blocking therapy (atenolol, 46 ± 9.4 mg/
day), their left ventricular ejection fraction was within normal 
limits (0.61 ± 0.06), and their clinical classification was Killip 
class I. For the healthy group, 28 volunteers were evalu-
ated and 11 who presented no evidence of cardiovascular, 
respiratory, musculoskeletal, and/or metabolic anomalies 
were included. Participants in this group were taking no 
medications and did not smoke or drink. 
Volunteers from both groups were attended by the hos-
pital medical team, undergoing clinical and cardiovascular 
evaluation as well as biochemical blood tests [total cho-
lesterol and fractions (HDL, LDL), glycemia, triglycerides, 
creatinine, and uric acid]. 
The diagnosis of AMI was confirmed by the presence 
of two or more of the following criteria: 1) precordialgia or 
retrosternal pain, either constrictive or burning, whether ra-
diating or not to the upper limbs, neck and back, that lasted 
>30 min and was not treated with vasodilators; 2) elevation 
of segment ST >1 mm in at least two or more contiguous 
derivations in the electrocardiogram (ECG); 3) elevation of 
the myocardial necrosis markers creatine kinase-MB and 
creatine phosphokinase to twice the normal values (16).
This cross-sectional study was approved by the Ethics 
Committee of Universidade Metodista de Piracicaba (pro-
tocol #63/06). The relevance and experimental procedures 
of the study were described to the volunteers, who signed 
a free informed consent form. 
Experimental procedures 
HR and blood pressure (BP) data from the AMI group 
were collected in the coronary units on the 2nd and 7th 
day after the coronary event, and data collection from the 
healthy group was performed at the institution’s research 
laboratory. All protocols were carried out by the same re-
searchers and in the morning to avoid circadian influence 
on the variables studied. The data collection environments 
were climate controlled, with temperature and relative 
humidity of approximately 23°C and 50%, respectively. 
Volunteers were instructed to avoid caffeine, alcohol and 
strenuous exercise on the day before the protocol. On the 
day of the experiment, the volunteers were interviewed to 
determine whether they had followed the instructions and if 
the control conditions (HR and BP) were within the normal 
range. While in the supine position, subject BP was checked 
three times using the Korotkoff auscultatory method with 
a mercury-column sphygmomanometer (WanMed, Brazil) 
and a stethoscope (Littman, USA).
In order to reduce anxiety, the volunteers were familiarized 
with the equipment and the protocol before the experiment. 
Experimental protocol
First, the subjects were kept resting in the supine posi-
tion for 10 min. Next, HR and RRi were recorded continu-
ously for 15 min with a digital telemetry system consisting 
of a transmitter placed on the patient’s chest and an HR 
monitor (Polar® S810i; Polar Electro, Oy, Finland). The 
system detects ventricular depolarization, corresponding 
to the R wave on the ECG, with a sampling rate of 500 
Hz and a temporal resolution of 1 ms (17), and has been 
previously validated by Loimaala et al. (18), Gamelin et al. 
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(19), and Vanderlei et al. (20). The RRi captured with the 
HR monitor can be analyzed with both linear and nonlinear 
models, including ApEn (21). After recording, the signals 
were transmitted to a receiver and interface connected to 
a computer for subsequent analysis.
Data analysis 
Resting HR evaluation was based on the mean value 
of the 15-min assessment and BP evaluation was based 
on the mean value of BP measurements.
The first step in the data analysis involved a visual inspec-
tion of RRi (ms) distribution in the ECG in order to select the 
sections with the highest signal stability. Ectopic beats were 
excluded and 700 data points were used in the analysis.
HRV analysis was carried out using the following linear 
methods: A) in the time domain, RMSSD (square root of the 
mean of the sum of the squares of differences) between 
adjacent RRi divided by the number of RRi minus one, 
expressed in ms) and RMSM (square root of the sum of the 
squares of differences of individual values compared to the 
mean value, divided by the number of RRi in a period) (1); 
B) in the frequency domain, an autoregressive algorithm 
was used (22,23). Using power spectrum components, very 
low frequency (VLF = 0.003 at 0.04 Hz), low frequency (LF 
= 0.04 at 0.15 Hz) and high frequency bands (HF = 0.15 at 
0.4 Hz) were obtained, as well as the ratio between absolute 
Figure 1. Flowchart of sample loss.
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LF and HF areas (LF/HF ratio). Normalization was carried 
out by dividing the absolute power of a given component 
ms2 (LF or HF) by the total power spectrum, subtracting the 
VLF component and multiplying by 100. HF and LF bands 
represent the action of vagal and sympathetic components 
in HR regulation, respectively (1). 
The nonlinear method (ApEn) was carried out by the 
method of Pincus (13,14). The basic idea of ApEn is to de-
termine the correlation measure for blocks of m samples of 
signal. Let xi and xj be any pair of blocks of size m samples 
of u(1), u(2), ... , u(N) signal, N the number of signal samples, 
a positive integer m (m ≤ N) indicates the size of the bocks 
used for comparison, and a positive number integer r sets 
the upper limit on the consideration of similarity between 
xi and xj. Thus, it is possible to define the following cor-
relation measure:
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In our experiments the following values were used for the 
variables: m = 2 (size of the blocks used for comparison), 
r = 20% multiplied by the standard deviation of the signal 
(upper limit for considering data similarity), and N = 700 
(number of data points in the signal).
Data were analyzed with MATLAB 6.5 (R13) using the 
HRV analysis routine. 
Statistical analysis 
According to the frequency distribution analysis (Kolm-
ogorov-Smirnov), the data were not normally distributed. In 
order to evaluate the relationship between the HRV analyses 
in the time and frequency domains and ApEn, a simple linear 
regression was applied to the AMI group on the 2nd and 7th 
day and to the healthy group. The Wilcoxon nonparametric 
test was used to compare the HRV data from the AMI group 
on the 2nd and 7th day after the coronary event. The Mann-
Whitney nonparametric test was used to compare the HRV 
data between the AMI group and the healthy group. The 
level of significance was established at 5% for all analyses. 
Calculations were performed using the BioEstat 5.0 soft-
ware (Brazil). A pre-study power analysis suggested that 
a minimum of 10 subjects in each group and a 5% level of 
significance would yield at least an 80% power.
Results
Sample characteristics
Table 1 presents the data for the AMI group and the 
healthy group regarding age, anthropometric characteris-
tics, resting cardiovascular variables, and clinical character-
istics, as well as risk factors for the AMI group. No significant 
differences were observed between groups. 
Analysis of HRV indexes
In the linear regression analysis between time and 
frequency domains and ApEn indexes, there was a sig-
nificant correlation between the AMI group on the 2nd and 
7th day after the coronary event and the healthy group 
(Table 2).
Figure 2A and B show that the RMSSD and RMSM 
HRV indexes of the healthy group were higher (P < 0.05) 
than those of the AMI group on the 2nd and 7th day. The 
indexes of the AMI group were similar on the 2nd and 7th 
day (P > 0.05). Frequency domain analysis revealed a 
higher LFnu (normalized unit) index (Figure 2C) and LF/
HF (Figure 2E) and a lower HFnu index (Figure 2D) in 
the AMI group on the 2nd and 7th day compared to the 
healthy group (P < 0.05), indicating that the healthy group 
presented lower sympathetic modulation and higher va-
gal modulation than the AMI group. No differences were 
found in the intergroup comparison for these indexes (P 
> 0.05). There were also no significant intergroup dif-
ferences in the nonlinear HRV analysis based on ApEn 
(Figure 2E; P > 0.05), although the healthy group values 
were higher (P < 0.05) than those of the AMI group on 
the 2nd and 7th day.
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 Table 1. Age, anthropometric characteristics, cardiovascular variables, and clinical characteristics 
of the groups studied.
AMI group (N = 10) Healthy group (N = 11) 
Age and anthropometric characteristics
Age (years) 57.10 ± 9.22 53.45 ± 3.42
Height (m) 1.67 ± 0.04 1.69 ± 0.05
Body mass (kg) 74.60 ± 13.09 79.59 ± 8.34
Body mass index (kg/m2) 26.81 ± 4.22 27.86 ± 3.11
Cardiovascular variables 
Heart rate (bpm) 65.70 ± 10.86 70.18 ± 9.58
Systolic blood pressure (mmHg) 126.00 ± 13.49 116.42 ± 6.43
Diastolic blood pressure (mmHg) 76.00 ± 10.74 77.73 ± 4.10
Clinical characteristics
Smoking 5 (50) 0 (0)
High blood pressure ≥140/90 mmHg 2 (20) 0 (0)
Fasting hyperglycemia ≥126 mg/dL 3 (30) 0 (0)
Hypercholesterolemia >240 mg/dL 3 (30) 0 (0)
Hypertriglyceridemia >200 mg/dL 4 (40) 0 (0)
AMI location
Anterior 3 (30) -
Posteroinferior 7 (70) -
Killip clinical class I 10 (100)
LVEF >40% 10 (100) -
Reperfusion
Chemical 4 (40) -
Mechanical 6 (60) -
Medications 
β-blockers 10 (100) -
ACEI 2 (20) -
Data are reported as means ± SD, absolutes values and percentage. AMI = acute myocardial in-
farction; LVEF = left ventricular ejection fraction; ACEI = angiotensin-converting enzyme inhibitors. 
The Mann-Whitney test was used to compare age and anthropometric characteristics and cardio-
vascular variables between groups; there were no statistically significant differences. 
Table 2. Correlation between approximate entropy (ApEn) and indexes in time and frequency domains of HRV (RMSSD, 
RMSM, LFnu, HFnu, and LF/HF ratio) for the groups studied. 
AMI group, 2nd day (N = 10) AMI group, 7th day (N = 10) Healthy group (N = 11)
R2 r P R2 r P R2 r P
ApEn
RMSSD (ms) 0.72 0.87 0.00 0.75 0.88 0.00 0.34 0.63 0.03
RMSM (ms) 0.35 0.65 0.03 0.43 0.70 0.02 0.45 0.71 0.01
LFnu 0.46 0.72 0.01 0.41 0.69 0.02 0.33 0.63 0.03
HFnu 0.46 0.72 0.01 0.41 0.69 0.02 0.33 0.63 0.03
LF/HF ratio 0.33 0.64 0.04 0.74 0.87 0.00 0.50 0.74 0.00
AMI = acute myocardial infarction; R2 = determination coefficient; r = correlation coefficient; P = P value; ApEn = approximate 
entropy; RMSSD = square root of the mean of the sum of the squares of differences between R-R intervals (RRi) divided by 
the number of RRi in a determined time minus one; RMSM = square root of the sum of the squares of differences of individual 
values compared to the mean value divided by the number of RRi in a period; ms = milliseconds; LF = low frequency; HF = high 
frequency; nu = normalized units. The simple linear regression test was used to correlate HRV indexes.
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Discussion 
The results of the linear regression 
analysis between ApEn and linear meth-
ods in time and frequency domains in 
the present study demonstrate that the 
values of the coefficient of determina-
tion and the correlation coefficient were 
significant for both the AMI group on the 
2nd and 7th day after coronary event and 
the healthy group. These results differ 
from the findings of Makikallio et al. (2) 
who, when comparing HRV in time and 
frequency domains with ApEn in post-
AMI patients, observed that the lower 
the time and frequency domain values, 
the higher the ApEn values. The differ-
ences between our results and those of 
Makikallio et al. (2) could be attributed to 
data processing methodology and/or to 
their decision to interrupt β-blocker and 
angiotensin-converting enzyme inhibitor 
use before the tests. Thus, they reported 
that AMI contributed to an increase in 
sympathetic tonus, which was reflected 
in increased signal complexity, and that 
the β-adrenergic system participated 
little in nonlinear HRV dynamics (24). 
Nevertheless, we consider that the 
lack of difference we found between 
nonlinear ApEn analysis and both time 
and frequency domain indexes could be 
attributed to β-adrenoceptor blockade.
Beckers et al. (24) assessed sym-
pathetic and vagal activity in HR re-
sponse and observed that after partial 
pharmacological blockade of the vagal 
component there was a decrease in the 
nonlinear complexity of HRV, suggest-
ing that vagal activity is responsible for 
the introduction of complexity in HR 
variation. 
Krstacic et al. (4) found lower ApEn 
indexes in post-AMI patients than in 
healthy individuals and attributed this 
to the signal’s loss of complexity and 
irregularity due to reduced HRV, in-
creased sympathetic modulation and 
decreased vagal modulation.
Regarding the comparison of HRV indexes evaluated 
on the 2nd and 7th day after AMI, we found no differences 
between time and frequency domains or ApEn in our study. 
This similarity should be considered because of the short 
evaluation period, i.e., a 5-day interval. Another fact to be 
considered is the use of drugs, specifically β-blockers, and 
the application of chemical or mechanical reperfusion on 
the first day after AMI. 
According to Piegas et al. (16), β-blockers are first 
choice medicines for treating AMI since they reduce 
oxygen demand in the myocardium, HR, BP, and heart 
contraction. Lampert et al. (25) stated that these drugs, in 
Figure 2. Box plot (median, confidence interval, 1st and 3rd quartiles, maximum and 
minimum) showing the results of the time domain analysis [RMSSD = square root of 
the sum of the squares of differences between RRi divided by the number of RRi in 
a determined time minus one (A); RMSM = square root of the sum of the squares of 
differences of individual values compared to the mean value divided by the number of 
RRi in a period (B)], the frequency domain analysis [LF = low frequency (C) and HF = 
high frequency (D) nu (normalized units), and LF/HF ratio (E)] and the nonlinear model 
analysis [ApEn = approximate entropy (F)], comparing the acute myocardial infarc-
tion (AMI) group on the 2nd and 7th day to the healthy group. *P < 0.05, AMI group 
on the 2nd day compared to the healthy group (Mann-Whitney nonparametric test); 
**P < 0.05, AMI group on the 7th day compared to the healthy group (Mann-Whitney 
nonparametric test).
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addition to reducing the incidence of morbidity and mortal-
ity, act directly on the autonomic nervous system because 
they specifically antagonize the action of catecholamine 
on β-adrenergic receptors and consequently alter HRV 
indexes by reducing sympathetic activity and promoting 
parasympathetic recovery. 
Considering the effects of β-blockers on the autonomic 
modulation of HR, we verified that, even though all patients 
from the AMI group were taking these drugs, the HRV 
indexes were similar on the 2nd and 7th day after the 
coronary event. Similarly, Carpeggiani et al. (26) observed 
no differences in HRV indexes when comparing the time of 
admission to and discharge from the hospital. 
On the other hand, it has been reported that AMI 
patients who began the use of β-blockers between the 
5th and 21st day after hospital admission and continued 
to use them for 6 weeks presented significant increases 
in time domain (RMSSD) and frequency domain (HF 
component) indexes, as well as a decrease in the LF/HF 
ratio (25). These results could be attributed to the period 
of β-blocker use, which has effects on the autonomic 
modulation of HR.
However, it is important to consider that successful 
chemical or mechanical reperfusion carried out immedi-
ately after AMI contributes to the preservation or increase 
of autonomic function, yielding HRV index values close to 
the normal range. Nevertheless, it has been observed that 
autonomic modulation of HR begins to recover from 30 to 
60 days after angioplasty (27). 
Regarding the coronary reperfusion of patients in the 
present study, which was carried out on the first day of 
admission and followed up with HRV analysis on the 2nd 
and 7th day, the time and frequency domains and ApEn 
indexes were similar. These results agree with Doulalas et 
al. (28) and Bonnemeier et al. (29), who reported that HRV 
indexes are not altered between the 1st and 5th day. 
The reduction in the AMI group’s HRV indexes com-
pared to those of healthy individuals could be attributed to 
alterations in autonomic modulation in the sinoatrial node, 
reflected on lower vagal modulation and higher sympa-
thetic modulation. Previous studies have reported that the 
alterations in autonomic modulation of HR after an ischemic 
cardiac event are due to modifications in ionic currents 
across the cell membrane, leading to electrical instability 
in the myocytes that promotes increased ventricular work 
and oxygen demand (25,27,30,31).
It is important to point out that the LFnu (0.79) and LF/
HF (3.94) values we observed indicated an increase in the 
sympathetic autonomic modulation of post-AMI patients 
compared to healthy individuals. Carpeggiani et al. (26) 
evaluated the HRV response and observed greater LF/HF 
values in AMI patients who were still in the hospital than in 
healthy individuals. Similarly, Barbosa et al. (32) observed 
that patients with cardiac insufficiency also presented im-
portant alterations in the sympathetic and parasympathetic 
systems.
Regarding the ApEn results, our study agrees with 
Krstacic et al. (4), who observed ApEn values of 0.94 ± 0.13 
in an AMI group. Moreover, our data are also similar to the 
results of Acharya et al. (33), who observed ApEn values 
of 1.68 for healthy, middle-aged individuals.
The intergroup ApEn differences could be attributed 
to the disease process. In AMI there is a loss of chaotic 
behavior (nonlinear) in favor of cyclic behavior or lack of 
variability, which represents a higher risk of abnormality 
and even mortality (15).
The present study was limited by the difficulty in selecting 
a sample that would satisfy the proposed inclusion criteria. 
More detailed studies with larger samples are needed, as 
well as cross-sectional studies that include patients with 
AMI who have not received β-blocker therapy.
Clinical implications 
HRV analysis using linear and nonlinear methods is 
considered to be important for evaluating and understand-
ing cardiac autonomic modulation in pathological situations 
like AMI. 
In summary, we observed that the HRV of the sample of 
AMI group patients who used β-blockers and were treated 
with coronary reperfusion was similar on the 2nd and 7th 
day. However, upon comparing post-AMI patients with 
healthy individuals, we observed that patients with AMI 
presented greater sympathetic modulation and a reduction 
in vagal modulation. HRV results from linear methods in the 
time and frequency domains agreed with those obtained 
by the nonlinear method ApEn. This suggests that linear 
methods in time and frequency domains and nonlinear 
methods like ApEn can be employed in the evaluation of 
the autonomic modulation of HR both in healthy subjects 
and in post-AMI patients.
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